Cargando…
Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy
Until recently, ovarian clear cell carcinoma was recognized by its unique morphology and unfavorable patient outcome primarily due to tumor chemoresistance. Recently, specific molecular characteristics of ovarian clear cell carcinoma, such as PI3CA mutation, ARID1a mutation and MET amplification, ha...
Autor principal: | Yamashita, Yoriko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4412138/ https://www.ncbi.nlm.nih.gov/pubmed/25583423 http://dx.doi.org/10.1093/jjco/hyu221 |
Ejemplares similares
-
The target therapy of ovarian clear cell carcinoma
por: Jin, Ying, et al.
Publicado: (2014) -
New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
por: Tan, D S P, et al.
Publicado: (2013) -
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
por: Amano, Tsukuru, et al.
Publicado: (2021) -
Could cannabinoids provide a new hope for ovarian cancer patients?
por: Kaur, Rimanee, et al.
Publicado: (2023) -
Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
por: Kiaie, Seyed Hossein, et al.
Publicado: (2021)